Trials / Not Yet Recruiting
Not Yet RecruitingNCT06071208
Prevent Diabetic Kidney Disease Among Egyptians
The National Plan To Prevent Diabetic Kidney Disease Among Egyptians: A Prospective Multicenter Randomized Controlled Study
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,000 (estimated)
- Sponsor
- Fayoum University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Study of the possibility to prevent the development of Diabetic kidney disease in type 2 diabetic patients
Detailed description
Study of the possible role of the SGLT2 inhibitors to prevent the development of frank type2 DM among prediabetic candidates. Study of the possible role of the SGLT2 inhibitors to prevent the development of diabetic complications, namely diabetic kidney disease, diabetic retinopathy and neuropathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gliflozin | to study whether the use of gliflozin prevented diabetic complications |
Timeline
- Start date
- 2023-10-14
- Primary completion
- 2028-10-14
- Completion
- 2028-12-14
- First posted
- 2023-10-06
- Last updated
- 2023-10-10
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06071208. Inclusion in this directory is not an endorsement.